Erratum: Clinical management of hypertension in pregnancy: Practical recommendations from the italian society of hypertension (SIIA) (High Blood Pressure and Cardiovascular Prevention DOI: 10.1007/s40292-013-0019-y);Clinical management of hypertension in pregnancy

High Blood Pressure and Cardiovascular Prevention

Volumn 20, Issue 3, 2013, Pages 123-127

  Borghi, Claudio ^a   Ferri, Claudio ^b   Sechi, Leonardo ^c  

^a UNIVERSITY OF BOLOGNA   (Italy)

^b UNIVERSITY OF L'AQUILA   (Italy)

^c UNIVERSITY OF UDINE   (Italy)

Author keywords

Guidelines; Hypertension; Preeclampsia; Pregnancy

Indexed keywords

ACETYLSALICYLIC ACID; BETA ADRENERGIC RECEPTOR BLOCKING AGENT; CALCIUM; CALCIUM CHANNEL BLOCKING AGENT; FISH OIL; GLYCERYL TRINITRATE; LABETALOL; MAGNESIUM SULFATE; METHYLDOPA; NIFEDIPINE; NITROPRUSSIDE SODIUM; PROPRANOLOL; THIAZIDE DIURETIC AGENT;

ANTIHYPERTENSIVE THERAPY; ARTICLE; BLOOD PRESSURE MEASUREMENT; BLOOD PRESSURE MONITORING; CEREBROVASCULAR ACCIDENT; DIABETES MELLITUS; DISEASE SEVERITY; GESTATIONAL AGE; HUMAN; HYPERTENSION; INSULIN RESISTANCE; LACTATION; LOW DRUG DOSE; MATERNAL HYPERTENSION; MATERNAL MORBIDITY; MATERNAL MORTALITY; PERINATAL MORBIDITY; PREECLAMPSIA; PRIORITY JOURNAL; PROTEINURIA; PUERPERAL DEPRESSION; RESISTANT HYPERTENSION; SALT INTAKE; SODIUM RESTRICTION; VITAMIN SUPPLEMENTATION;

ANTIHYPERTENSIVE AGENTS; BLOOD PRESSURE; BLOOD PRESSURE DETERMINATION; CARDIOLOGY; COMBINED MODALITY THERAPY; DRUG THERAPY, COMBINATION; FEMALE; HUMANS; HYPERTENSION, PREGNANCY-INDUCED; MATERNAL HEALTH SERVICES; PREDICTIVE VALUE OF TESTS; PREGNANCY; RISK FACTORS; TREATMENT OUTCOME;

EID: 84885666062     PISSN: 11209879     EISSN: 11791985     Source Type: Journal    
DOI: 10.1007/s40292-013-0025-0     Document Type: Erratum

References (18)

1. Bramlage P, Bohm M, Volpe M, Khan BV, Paar WD, Tebbe U, et al. A global perspective on blood pressure treatment and control in a referred cohort of hypertensive patients. J Clin Hypertens (Greenwich). 2010;12(9):666-77.
2. Ignatius J. "RR 160/80" Scipione Riva-Rocci (1863-1937). Duodecim. 1993;109(17):1493-4.
3. Prugger C, Keil U, Wellmann J, de Bacquer D, de Backer G, Ambrosio GB, et al. Blood pressure control and knowledge of target blood pressure in coronary patients across Europe: results from the EUROASPIRE III survey. J Hypertens. 2011;29(8):1641-8.
4. Chobanian AV. Shattuck Lecture. The hypertension paradox - more uncontrolled disease despite improved therapy. N Engl J Med. 2009;361(9):878-87.
5. Volpe M, Tocci G, Trimarco B, Rosei EA, Borghi C, Ambrosioni E, et al. Blood pressure control in Italy: results of recent surveys on hypertension. J Hypertens. 2007;25(7):1491-8.
6. Hartmann B, Weise H, Bassenge E. Quality assurance in Riva-Rocci blood pressure measurement: simultaneous sphygmomanometry with open and covered pressure display. Z Kardiol. 1988;77(8):537-42.
7. Volpe M, Rosei EA, Ambrosioni E, Cottone S, Cuspidi C, Borghi C, et al. 2012 Consensus Document of the Italian Society of Hypertension (SIIA): strategies to improve blood pressure control in Italy: from global cardiovascular risk stratification to combination therapy. High Blood Press Cardiovasc Prev. 2013;20(1):45-52.
8. Volpe M, Rosei EA, Ambrosioni E, Cottone S, Cuspidi C, Borghi C, et al. Renal artery denervation for treating resistant hypertension: definition of the disease, patient selection and description of the procedure. High Blood Press Cardiovasc Prev. 2012;19(4):237-44.
9. Mancia G, De Backer G, Dominiczak A, Cifkova R, Fagard R, Germano G, et al. 2007 ESH-ESC practice guidelines for the management of arterial hypertension: ESH-ESC task force on the management of arterial hypertension. J Hypertens. 2007;25(9):1751-62.
10. Mancia G, Laurent S, Agabiti-Rosei E, Ambrosioni E, Burnier M, Caulfield MJ, et al. Reappraisal of European guidelines on hypertension management: a European Society of Hypertension Task Force document. J Hypertens. 2009;27(11):2121-58.
11. Chobanian AV, Bakris GL, Black HR, Cushman WC, Green LA, Izzo JL Jr, et al. The seventh report of the joint national committee on prevention, detection, evaluation, and treatment of high blood pressure: the JNC 7 report. JAMA. 2003;289(19):2560-72.
12. Mancia G, Fagard R, Narkiewicz K, Redon J, Zanchetti A, Bohm M, et al. 2013 ESH/ESC Guidelines for the management of arterial hypertension: the task force for the management of arterial hypertension of the European Society of Hypertension (ESH) and of the European Society of Cardiology (ESC). Eur Heart J. 2013;2230-50.
13. Regitz-Zagrosek V, Blomstrom Lundqvist C, Borghi C, Cifkova R, Ferreira R, Foidart JM, et al. ESC Guidelines on the management of cardiovascular diseases during pregnancy: The task force on the management of cardiovascular diseases during pregnancy of the European Society of Cardiology (ESC). Eur Heart J. 2011;32(24):3147-97.
14. Borghi C, Cicero AF, Degli Esposti D, Immordino V, Bacchelli S, Rizzo N, et al. Hemodynamic and neurohumoral profile in patients with different types of hypertension in pregnancy. Intern Emerg Med. 2011;6(3):227-34.
15. Borghi C, Esposti DD, Immordino V, Cassani A, Boschi S, Bovicelli L, et al. Relationship of systemic hemodynamics, left ventricular structure and function, and plasma natriuretic peptide concentrations during pregnancy complicated by preeclampsia. Am J Obstet Gynecol. 2000;183(1):140-7.
16. Mancia G, De Backer G, Dominiczak A, Cifkova R, Fagard R, Germano G, et al. 2007 Guidelines for the management of arterial hypertension: the task force for the management of arterial hypertension of the European Society of Hypertension (ESH) and of the European Society of Cardiology (ESC). Eur Heart J. 2007;28(12):1462-536.
17. Catena C, Novello M, Lapenna R, Baroselli S, Colussi G, Nadalini E, et al. New risk factors for atherosclerosis in hypertension: focus on the prothrombotic state and lipoprotein(a). J Hypertens. 2005;23(9):1617-31.
18. Colussi G, Catena C, Sechi LA. Spironolactone, eplerenone and the new aldosterone blockers in endocrine and primary hypertension. J Hypertens. 2013;31(1):3-15.